Ginsenoside Rg5 NEW
| Price | $115 | $279 | $449 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Ginsenoside Rg5 | CAS No.: 186763-78-0 |
| Purity: 98.07% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Ginsenoside Rg5 |
| Description | 1. Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease. 2. Ginsenoside Rg5 suppresses LPS-induced nitric oxide (NO) production and proinflammatory TNF-α secretion. 3. Ginsenoside Rg5 can ameliorate lung inflammation possibly by inhibiting the binding of LPS to toll-like receptor (TLR)-4 on macrophages. 4. Ginsenoside Rg5 plays a novel role as an IGF-1R agonist, promoting therapeutic angiogenesis and improving hypertension without adverse effects in the vasculature. 5. Ginsenoside Rg5 blocks cell cycle of SK-HEP-1 cells at the Gl/S transition phase by down-regulating cyclin E-dependent kinase activity and that the down-regulation of cyclin E-dependent kinase activity is caused mainly by induced CDK2 inhibitor, p21Cip/WAF1 and decreased levels of cyclin E. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 60 mg/mL (78.23 mM) |
| Keywords | Nuclear factor-κB | Inhibitor | Cyclooxygenase | Ginsenoside Rg 5 | NF-κB | Ginsenoside Rg5 | COX | Nuclear factor-kappaB | IGF-1R | inhibit | Ginsenoside Rg-5 |
| Inhibitors Related | Bismuth Subsalicylate | Ibuprofen | Acetaminophen | Diclofenac sodium | Diethylmaleate | Glucosamine | Diclofenac Potassium | Lidocaine hydrochloride | Indole-3-carbinol | Paradol | Diallyl disulfide | Salicylic acid |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Pain-Related Compound Library | Tyrosine Kinase Inhibitor Library | Selected Plant-Sourced Compound Library | Saccharide and Glycoside Natural Product Library | Anti-Inflammatory Traditional Chinese Medicine Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/25kg |
Shaanxi Haibo Biotechnology Co., Ltd
|
2023-12-05 | ||
| $0.00/10mg |
Shanghai Standard Technology Co., Ltd.
|
2020-04-23 | ||
| $357.00/1KG |
NanJing Spring & Autumn Biological Engineering CO., LTD.
|
2020-03-04 | ||
| $7.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-02-13 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY